Bayer begins Phase Ib study of VVD-214 in advanced CRC
The study evaluates the WRN inhibitor in combination therapy for patients with MSI-high or dMMR advanced colorectal cancer who have been previously treated.
See the latest news and media coverage for Bayer. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life science company in healthcare and agriculture
bayer.comLast updated
In short: Bayer achieved significant legal and regulatory progress, including advancements in Roundup settlements and receiving multiple FDA priority reviews.
The study evaluates the WRN inhibitor in combination therapy for patients with MSI-high or dMMR advanced colorectal cancer who have been previously treated.
The ruling returns jurisdiction to state court, allowing the approval process to continue and rendering JPML proceedings moot.
The deal adds a novel treatment for retinal diseases to Bayer's pipeline.
The new hub in Shandong focuses on co-developing self-care solutions in skin and digestive health with partners.
A group of NGOs accuses the Bayer Group of failing to fulfill its responsibility in the use of genetically modified soy and glyphosate in Latin America. A complaint has been...
Bayer receives planning security from US judge, but geopolitical tensions in the Middle East weigh on stock sentiment.
Bayer stock under pressure: US investigation into drug prices, glyphosate ruling and Nubeqa dispute weigh despite significant price recovery.
Human rights organisation Medico International and the German network “Coordination gegen Bayer-Gefahren“ (Coordination against Bayer Dangers, CBG) have reported that the glyphosate and white phosp...
Track Bayer and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.